Page last updated: 2024-08-23

paclitaxel and Mast Cell Activation Disease

paclitaxel has been researched along with Mast Cell Activation Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Krell, J; Lythgoe, MP; McNeish, IA; Tookman, L1

Other Studies

1 other study(ies) available for paclitaxel and Mast Cell Activation Disease

ArticleYear
Safe administration of chemotherapy in mast cell activation syndrome.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Mastocytosis; Middle Aged; Paclitaxel

2021